UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549


FORM 15


CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.


Commission File Number 000-30651


CTT PHARMACEUTICAL HOLDINGS, INC.

(Exact name of registrant as specified in its charter)


429 Kent Street

Unit 112

Ottawa, Ontario Canada K1Z 8P8

(613)241-9959

(Address, including zip code, and telephone number, including area code,
of registrant’s principal executive offices)


Common Stock, $0.0001 par value

(Title of each class of securities covered by this Form)


None

(Titles of all other classes of securities for which a duty to file reports
under section 13(a) or 15(d) remains)


Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:


Rule 12g-4(a)(1)

 

     

 

 

 

 

 

 

 

Rule 12g-4(a)(2)

x

 

 

 

 

 

 

 

 

Rule 12h-3(b)(1)(i)

 

 

 

 

 

 

 

 

 

Rule 12h-3(b)(1)(ii)

 

 

 

 

                                      

 

 

                                    

 

Rule 15d-6 

 

 

 

 

 

 

 

 

 

Rule 15d-22(b)

 

 

 

 


Approximate number of holders of record as of the certification or notice date: 314


Pursuant to the requirements of the Securities Exchange Act of 1934, CTT PHARMACEUTICAL HOLDINGS, INC. has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.


Date: March 29, 2016

By:

/s/ Pankaj Modi

 

 

Name: Pankaj Modi

 

 

Title: chief executive officer and director




CTT Pharmaceutical (PK) (USOTC:CTTH)
Gráfica de Acción Histórica
De May 2024 a Jun 2024 Haga Click aquí para más Gráficas CTT Pharmaceutical (PK).
CTT Pharmaceutical (PK) (USOTC:CTTH)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024 Haga Click aquí para más Gráficas CTT Pharmaceutical (PK).